Case report. High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

By de Jong D  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 573-575

Oxford University Press

Access to resources Recommend Favorite

Recurrent cholestasis following ovarian hyperstimulation syndrome: Case report

By  

Human Reproduction, Vol. 14, Iss. 11, 1999-11 ,pp. : 2926-2926

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recurrent cholestasis following ovarian hyperstimulation syndrome: Case report

By Midgley D.Y.   Khalaf Y.   Braude P.R.  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2249-2251

Oxford University Press

Access to resources Recommend Favorite

Case report. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)

By Itskovitz-Eldor J  

Human Reproduction, Vol. 13, Iss. 2, 1998-02 ,pp. : 294-295

Oxford University Press

Access to resources Recommend Favorite

Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone

By Weissman A  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3421-3424

Oxford University Press

Access to resources Recommend Favorite